- +86 1872918458
- maggie@sinotcell.com
- High-tech Zone,Xi’an, Shaanxi, China
Relying on China’s leading hematologic malignancy diagnosis and treatment technologies and rich experience in serving international patients, we provide you with professional and comprehensive treatment support
1.International Cutting-edge Treatment Technologies
• CAR-T cell therapy: China has approved 6 CAR-T products, covering B-ALL, DLBCL, and multiple myeloma
• China independently developed FUCASO® (Equecabtagene Autoleucel) is the world’s first fully human BCMA CAR-T product
• New immunotherapy approaches such as bispecific antibodies and ADC drugs
2.Personalized and Precision Medicine
• Molecular classification based on genetic testing guides treatment selection
• MRD (minimal residual disease) monitoring guides treatment decisions
• Multidisciplinary team (MDT) consultations formulate the optimal plan
3.High Cost-effective Medical Services
• The cost of CAR-T therapy is about 50–70% of that in European and American countries
• Treatment of the same quality at a more favorable price
• Transparent fee structure, no hidden charges
4.Fast Medical Access Channel
• No long waiting required, fast arrangement for hospitalization
• Exclusive green channel for international patients
• Rapid response from consultation to treatment
• Multiple professor-level experts, with an average of over 25 years of professional experience
• Advanced training experience at well-known hematology centers both domestically and internationally
• Participated in multiple international multicenter clinical trials
• One of the first medical teams in China to carry out CAR-T therapy
• Have completed hundreds of CAR-T cell therapy cases, with rich experience
• Experience in collaborating with treatment centers certified by the U.S. FDA and the European Union EMA
• Joint diagnosis and treatment by experts from hematology, oncology, transplantation, imaging, and pathology departments
• Regular MDT meetings to formulate the best plans for complex cases
• Maintain academic exchange and cooperation with top international medical centers
• Professional hematologic malignancy nursing team, providing 24-hour attentive care
• Psychological support team, helping patients and their families cope with treatment stress
• Nutritionist team, providing personalized nutritional guidance
• Multilingual services (English, Arabic, Russian, Spanish, etc.)
• Dedicated customer service for international patients, providing full-process accompaniment services
• Familiar with international medical procedures, assisting in handling various matters
• Overall response rate (ORR) of CAR-T therapy: 70–90%
• Complete remission rate (CR): 40–60%
• 12-month progression-free survival rate: 40–50%
• Treatment-related mortality rate: <5%
• Patient satisfaction rate: over 95%
China has world-leading CAR-T treatment technology and rich clinical experience, and the treatment cost is only 50–70% of that in European and American countries, while providing high-quality medical services and full-process support.
Our overall response rate of CAR-T therapy reaches 70–90%, and the complete remission rate is 40–60%, comparable to top international medical centers. The specific success rate varies depending on the disease type and patient condition.
We provide multilingual professional interpretation services, and dedicated customer service for international patients accompanies them throughout the process to ensure barrier-free communication between doctors and patients. Medical documents are also provided in English versions.
We provide long-term follow-up services, including regular re-examinations, remote consultations, relapse monitoring, etc. International patients can choose to undergo re-examinations locally and obtain medical advice through remote consultations.
Simply submit the medical records, and we will provide a preliminary evaluation within 24 hours. After the evaluation is approved, we will assist in applying for a medical visa, arranging travel, booking accommodation, etc.
Understand the Basic Knowledge of Hematologic Malignancies—Comprehensive analysis of disease types, diagnostic methods, and treatment options
Evaluate Whether You Are Suitable for Our Treatment—Understand treatment indications and patient evaluation criteria
Gain an in-depth understanding of CAR-T treatment technology and advantages
Read more successful cases to gain hope and confidence
